Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)

Market Cap	32.53B -27.5%
Revenue (ttm)	8.75B -48.5%
Net Income	-14.78B
EPS	-6.18
Shares Out	2.39B
PE Ratio	n/a
Forward PE	10.49
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,522,738
Open	14.49
Previous Close	13.71
Day's Range	13.59 - 14.49
52-Week Range	13.11 - 26.00
Beta	0.59
Analysts	Hold
Price Target	21.90 (+61.15%)
Earnings Date	Aug 28, 2026

About SHE:300122

Chongqing Zhifei Biological Products Co., Ltd., a biopharmaceutical company, engages in the research and development, production, sale, and distribution of vaccine and biological products in China. The company offers recombinant COVID-19 vaccine; recombinant mycobacterium tuberculosis fusion protein products; group A and C meningococcal polysaccharide vaccine; ACYW135 meningococcal polysaccharide vaccine; Haemophilus Influenza type B conjugate vaccine; mycobacterium injection under the Vaccae brand; and meningococcal group A and C conjugate vac...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 6,292
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300122